Global Healthcare Distribution Market is Estimated to Value Over USD 4.5 Billion by 2026 End

  • 11 Oct 2019

Global Healthcare Distribution Market is estimated to value over USD 4.5 billion by 2026 end and register a CAGR of over 13% during the forecast period 2019 to 2026.


Based on the market analysis, the global healthcare distribution market growth is largely propelled by the rise in the number of chronic diseases, the expansion of industries manufacturing medical tools and devices, and by prioritising on the generics. Moreover, thriving markets in India and China, expansion of the biosimilars market, the extensive specialty drug dispensing, as well as the stronghold of biopharmaceuticals are factors which are likely to augment the economic development over the forecast period. However, factors such as a hike in the price points, may prove to be detrimental to the future growth.


The regions of North America and Europe captured considerable global healthcare distribution market share. In North America, particularly, the drug distribution channels are closely monitored by the U.S. food and drug administration (FDA) to allow only those drugs that have undergone safety measures, and that can be effectively and efficiently consumed with little to no assistance from a health care professional and can be easily dispensed without the need for a prescription.


Moreover, biotechnology, pharmaceutical and medical device manufacturers seemed to have increased their footprints in these regions. Global healthcare distribution market trends demonstrate that the boost in government officiated endeavours on generic drugs, the significant rise in chronic diseases, the soaring demand for specialty and biologics drugs, rigid regulations enacted in the distribution channels and the prevalence of innovative healthcare facilities has assisted in the augmentation of the market. It has been observed that the market in the Asia Pacific holds great global healthcare distribution market potential and is expected to rise to the largest CAGR during the forecast time frame. This could be because of the regulatory guidelines and requirements of APAC nations to adhere to the production and distribution methods and the rise in the volume of biotechnology and pharmaceutical companies in this region.


Key players that dominate the healthcare distribution market includes FFF Enterprises (US), Owens & Minor, Inc. (US), McKesson Corporation (US), Mutual Drug (US), CuraScript SD (US), Rochester Drug Cooperative, Inc. (US),  Medline Industries (US), Patterson Companies Inc. (US), AmerisourceBergen Corporation (US), Morris and Dickson Co., LLC (US), Henry Schein Inc. (US), Smith Drug Company (US), Cardinal Health, Inc. (US), Shanghai Pharmaceutical Group Co., Ltd. (China), Henry Schein Inc. (US), PHOENIX Group (Germany), and KeySource Medical, Inc. (US).


Global Healthcare Distribution Services Market Segmentation:

By Type

  •    Over-The-Counter Drugs/Vitamins
  •    Brand-Name/Innovator Drugs
  •    Generic Drugs
  •    Medical Device Distribution Services
  •    Biopharmaceutical Product Distribution Services
  •    Monoclonal Antibodies
  •    Vaccines
  •    Recombinant Proteins
  •    Blood and Blood Products
  •    Other Products

By End User

  •     Retail Pharmacies
  •     Hospital Pharmacies
  •     Other End Users

By Region

  • Europe
  • North America
  • Asia Pacific
  • Rest of the World


FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth


Objectives of the Study:

  • To provide with an exhaustive analysis on the healthcare distribution market by type, by end user and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, industry-specific restraints and opportunities)
  • To forecast and evaluate micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa
  • To record , evaluate and analyze competitive landscape mapping- technological advancements, product launches, expansions and mergers


Get unlimited analyst support and customise this study further to your requirements, contact